← Back to Search

Decision Aid vs Genetic Counseling for Ovarian and Pancreatic Cancer

N/A
Recruiting
Led By Daniel C. Chung, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months
Awards & highlights

Study Summary

This trial will compare how effective an electronic decision aid tool is versus a traditional genetic counselor session for people with ovarian or pancreatic cancer.

Who is the study for?
This trial is for adults over 18 with ovarian or pancreatic cancer, being treated at Massachusetts General Hospital or Boston Medical Center. It's not open to those who can't consent, minors, have had genetic testing before, or have hereditary pancreatitis.Check my eligibility
What is being tested?
The study compares an electronic decision aid tool and traditional genetic counseling sessions to see which is more effective for gene panel testing in patients with certain types of cancer.See study design
What are the potential side effects?
Since this trial involves decision aids and counseling rather than drugs or medical procedures, there are no direct physical side effects. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with ovarian or pancreatic cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average change in knowledge survey score
Decisional Conflict Scores
Shared Decision Making Process Scores
Secondary outcome measures
Average Duration of Decision Making Process
Average time between genetic testing recommendation and sample collection
Percentage of participants choosing genetic testing
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Electronic decision aid armExperimental Treatment1 Intervention
Receive decision aid followed by an appointment with their oncologist.
Group II: Genetic counselor ArmActive Control1 Intervention
Receive pretest counseling with a genetic counselor.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,924 Previous Clinical Trials
13,193,073 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,485 Total Patients Enrolled
Daniel C. Chung, MDPrincipal InvestigatorMassachusetts General Hospital

Media Library

Electronic Decision Aid Clinical Trial Eligibility Overview. Trial Name: NCT05470920 — N/A
Pancreatic Adenocarcinoma Research Study Groups: Electronic decision aid arm, Genetic counselor Arm
Pancreatic Adenocarcinoma Clinical Trial 2023: Electronic Decision Aid Highlights & Side Effects. Trial Name: NCT05470920 — N/A
Electronic Decision Aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT05470920 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are being granted access to this experiment?

"Yes, this is an active trial recruiting 350 patients from 2 sites, as recent as September 28th, 2022."

Answered by AI

What are the goals that investigators hope to achieve with this clinical trial?

"The aim of this study is to compare the average change in knowledge scores among participants after a genetics session. Other outcomes that will be measured include the percentage of participants who choose to get genetic testing after the educational intervention, the ratio of participants who choose the small, intermediate, or broad testing panel, and the average time it takes between being recommended for genetic testing and having a sample collected."

Answered by AI
~185 spots leftby Oct 2025